Term ends May 6, 2029 · High confidence
20-year base term ends Jun 9, 2035
Held by Acura Pharmaceuticals, Inc.
Filed Jun 23, 2023 as application 18/213,524 · Granted Sep 22, 2026
Base term plus 104 days of patent term adjustment (USPTO delay) · capped by a resolved terminal disclaimer
Today
2015
2035
Clock starts
Jun 9, 2015
Jun 9, 2015
Term ends
May 6, 2029
May 6, 2029
Granted
Sep 22, 2026
Sep 22, 2026
base term
after the term ends
Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
104
Days of term adjustment
Read from the USPTO patent term adjustment record, not recalculated here.
Capped
Terminal disclaimer
Resolved from the filed document, referencing US 10,004,699, US 10,155,044, US 10,610,497, US 11,197,837, US 11,723,885, US 8,623,412, US 8,901,113, US 9,757,466.
None due
Maintenance fees
This term ends before the first maintenance fee's grace period does, 4 years from grant, so no fee can end it early.
5
Family applications on record here
Applications sharing this one's continuity chain, as the file histories and patent records this site holds name them. The family may have others.
This patent's term runs 104 days past its 20-year base term on prosecution delay. A terminal disclaimer resolved from the filed document caps it earlier. No maintenance fee can end this term early. Confidence: High. from the record
How we calculated this date
One row per rule, each showing its own input and what it did to the date. A step we could not verify says so instead of resolving itself.
| Step | Input | Date after this step | Confidence |
|---|---|---|---|
| Base term, 20 years from filing | Clock starts Jun 9, 2015, when application 14/734,364, the earliest non-provisional in its chain, was filed (this one was filed Jun 23, 2023) | Jun 9, 2035 | High confidence |
| Continuity chain | Every parent in the chain resolved | no change | High confidence |
| Patent term adjustment | +104 days, USPTO patent term adjustment record | Sep 21, 2035 | High confidence |
| Terminal disclaimer cap | Disclaimer resolved from the filed document (refs US 10,004,699, US 10,155,044, US 10,610,497, US 11,197,837, US 11,723,885, US 8,623,412, US 8,901,113, US 9,757,466) | capped to May 6, 2029 | High confidence |
| Patent term extension | None on file | no change | High confidence |
| Fee events | No maintenance fee can end the term early | In force | High confidence |
| Computed term end | The steps above, in order | May 6, 2029 | High confidence |
This family
| US 10,004,699 | In force Dec 2035 | Dec 2035 |
| US 10,610,497 | In force Jun 2035 | Jun 2035 |
| US 11,197,837 | In force Jun 2035 | Jun 2035 |
| US 11,723,885 | In force Jun 2035 | Jun 2035 |
| US 12,740,948 | this patent May 2029 | May 2029 |
Every application listed has its file history here. The family may have others.
Sources
Google Patents · The patent document at USPTO · Assignment records at USPTO
USPTO account required: This application in Patent Center · USPTO's maintenance fee lookup
Maintenance fee events come from USPTO's own fee records. Its fee lookup asks for the patent number and the application number.
Free plan: 3 watched companies. Pro: unlimited.
Alerts on its grants, lapses and transfers.
What's changing
May 2029
Term ends May 6, 2029. No further fees fall due before then
Note
The 104 days of patent term adjustment (USPTO delay) are read from the USPTO record, not recalculated by us
Disclaimer cap
This term is capped by a terminal disclaimer resolved from the filed document, referencing US 10,004,699, US 10,155,044, US 10,610,497, US 11,197,837, US 11,723,885, US 8,623,412, US 8,901,113, US 9,757,466.
Citations
We have no citation count for this patent yet. That is not the same as never having been cited.
Every date shows its work: the base term, any term adjustment or extension, any disclaimer cap, and the maintenance fee record, each with a confidence tier. How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
In force means the term is running and no lapse is on record. It is not a finding that the patent is valid.